Longevc

Longevc company information, Employees & Contact Information

Explore related pages

Related company profiles:

We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.

Company Details

Employees
22
Founded
-
Address
2001 L St Nw, Washington,district Of Columbia 20036,united States
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Washington, District of Columbia
Looking for a particular Longevc employee's phone or email?

Longevc Questions

News

LongeVC's Sergey Jakimov on why NIH cuts present opportunities for biotech investors - Axios

LongeVC's Sergey Jakimov on why NIH cuts present opportunities for biotech investors Axios

Constructive Bio raises fresh investment from LongeVC - Business Weekly

Constructive Bio raises fresh investment from LongeVC Business Weekly

LongeVC's Jakimov and Trotsyuk on the future of longevity biotech - drugdiscoverytrends.com

LongeVC's Jakimov and Trotsyuk on the future of longevity biotech drugdiscoverytrends.com

LongeVC: What longevity investors are really looking for - Health Tech World

LongeVC: What longevity investors are really looking for Health Tech World

Meet the investor: Sergey Jakimov - Longevity.Technology

Meet the investor: Sergey Jakimov Longevity.Technology

2 Ways To Encourage Clinical Trial Investor Funding - Clinical Leader

2 Ways To Encourage Clinical Trial Investor Funding Clinical Leader

Biotech Industry-Focused LongeVC Fund Launches Startup Accelerator Program Under Supervision of Rustam Gilfanov - The European Business Review

Biotech Industry-Focused LongeVC Fund Launches Startup Accelerator Program Under Supervision of Rustam Gilfanov The European Business Review

Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments - EU-Startups

Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments EU-Startups

Trogenix announces £70 million / $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers - GlobeNewswire

Trogenix announces £70 million / $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers GlobeNewswire

Rustam Gilfanov – Entrepreneur and Partner of the LongeVC Venture Fund - BBN Times

Rustam Gilfanov – Entrepreneur and Partner of the LongeVC Venture Fund BBN Times

Rustam Gilfanov – biography of the venture partner of the LongeVC Fund - CEOWORLD magazine

Rustam Gilfanov – biography of the venture partner of the LongeVC Fund CEOWORLD magazine

Meet the founder: Garri Zmudze - Longevity.Technology

Meet the founder: Garri Zmudze Longevity.Technology

Latvian startup Longenesis nabs €1 million to speed up the digitization of biomedical research - EU-Startups

Latvian startup Longenesis nabs €1 million to speed up the digitization of biomedical research EU-Startups

Rustam Gilfanov, LongeVC Fund, venture partner: background - Daily Scanner

Rustam Gilfanov, LongeVC Fund, venture partner: background Daily Scanner

Top Longevc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant